Festival of Genomics London 2018: GenomeAsia 100k is addressing the lack of genomic data from South Asians by launching the “Map the Gap” campaign.
The advancement of sequencing technology has had the singe biggest effect on genomics research. As it develops further, so does the scope of genomic research and applications.
During the Festival of Genomics London, global biotech company, Dante Labs announced the launch of its privately funded 10,000 European Genome Project.
A new nanopore technology for direct sequencing of long strands of DNA has resulted in the most complete human genome ever assembled with a single technology.
We attended ‘The Great Genome Sequencing Debate’ earlier this week, chaired by Vivienne Parry from Genomics England, to discuss the future of genomic testing.
BGI Genomics and Pacific Biosciences of California have announced an agreement by BGI Genomics to purchase an additional 10 Sequel Systems.
A team of researchers have sequenced the genome of the axolotl, and with its ability to regenerate limbs and organs, they are optimistic about what this will mean for the future of medical practices.
This year at SLAS 2018, the Formulatrix will be unveiling a concept for a novel automation platform that offers so many benefits to researchers preparing samples that it is surprising others have not beat them to the punch.
Beckman Coulter Life Sciences have launched a family of FormaPure reagent kits for extracting nucleic acid from often challenging formalin-fixed, paraffin-embedded (FFPE) tissues.
We bring genomics to the UK in our latest issue, as we look ahead to what this year’s Festival of Genomics London has to offer.
After raising $20 million in funding, Stratos Genomics is hoping that its DNA sequencing technology will take the field further as it prepares to break into the market in the coming year.
At ASHG, we spoke to Gavin Stone, Vice President of Marketing at Edico Genome, to discuss their World Record achievement in more detail, as well as the advantages offered by their DRAGEN tool.
As a part of an effort to understand what health issues might be particular to people in the Nevada region, The Healthy Nevada Project is planning to sequence the DNA of 40,000 Nevadans.
When a hepatitis C treatment called Harvoni was released in 2014, Dr. Ronald Cirillo knew it was a big deal.